3,3′-Diindolylmethane induction of p75NTR-dependent cell death via the p38 mitogen-activated protein kinase pathway in prostate cancer cells

Cancer Prevention Research

Volumn 2, Issue 6, 2009, Pages 566-571

  Khwaja, Fatima S ^a   Wynne, Shehla ^a   Posey, Isadora ^b   Djakiew, Daniel ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b UNIVERSITY OF THE DISTRICT OF COLUMBIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 INDOLEMETHANOL; 3,3 DIINDOLYLMETHANE; 5 METHYLINDOLE 3 ACETIC ACID; ANTINEOPLASTIC AGENT; ETODOLAC; INDOMETACIN; KETOROLAC; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUROTROPHIN RECEPTOR P75; NONSTEROID ANTIINFLAMMATORY AGENT; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; 3,3' DIINDOLYLMETHANE; 3,3'-DIINDOLYLMETHANE; DRUG DERIVATIVE; ECDYSTERONE; HYBRID PROTEIN; INDOLE DERIVATIVE; NERVE GROWTH FACTOR RECEPTOR; NERVE PROTEIN; NGFR PROTEIN, HUMAN; PONASTERONE A; TUMOR PROTEIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER CELL CULTURE; CELL DEATH; CELL STRAIN MCF 7; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN INDUCTION; ADENOCARCINOMA; ANIMAL; APOPTOSIS; BRASSICACEAE; BREAST TUMOR; CELL STRAIN 3T3; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; FEMALE; GENETIC TRANSFECTION; GENETICS; MALE; MOUSE; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; PROSTATE TUMOR; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

3T3 CELLS; ADENOCARCINOMA; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICARCINOGENIC AGENTS; APOPTOSIS; BRASSICACEAE; BREAST NEOPLASMS; CELL LINE, TUMOR; ECDYSTERONE; FEMALE; HUMANS; INDOLES; MALE; MICE; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROSTATIC NEOPLASMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, NERVE GROWTH FACTOR; RECOMBINANT FUSION PROTEINS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 68949173808     PISSN: 19406207     EISSN: None     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-08-0202     Document Type: Article

References (42)

1. Smith ML, Hawcroft G, Hull MA. The effect of nonsteroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action. Eur J Cancer 2001;36:664-674 (Pubitemid 30156854)
2. Behari J, Zeng G, Otruba W, et al. R-Etodolac decreases β-catenin levels along with survival and proliferation of hepatoma cells. J Hepatol 2007;46:849-857 (Pubitemid 46529036)
3. Bellosillo B, Piqué M, Barragán M, et al. Aspirin and salicylate induce apoptosis and activation of caspases in B-cell chronic lymphocytic leukemia cells. Blood 1998;92:1406-1414 (Pubitemid 28369055)
4. Garikapaty VP, Ashok BT, Chen YG, Mittelman A, Iatropoulos M, Tiwari RK. Anti-carcinogenic and anti-metastatic properties of indole-3-carbinol in prostate cancer. Oncol Rep 2005;13:89-93.
5. Chinni SR, Li Y, Upadhyay S, Koppolu PK, Sarkar FH. Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells. Oncogene 2001;20:2927-2936
6. Nachshon-Kedmi M, Yannai S, Haj A, Fares FA. Indole-3-carbinol and 3,3′diindolylmethane induce apoptosis in human prostate cancer cells. Food Chem Toxicol 2003;41:745-752 (Pubitemid 36555879)
7. Garikapaty VP, Ashok BT, Tadi K, Mittelman A, Tiwari RK. 3,3′diindolylmethane downregulates pro-survival pathway in hormone independent prostate cancer. Biochem Biophys Res Commun 2006;340:718-725
8. Hsu J, Dev A, Wing A, Brew CT, Bjeldanes LF, Firestine GL. Indole-3-carbinol mediated cell cycle arrest of LNCaP human prostate cancer cells requires the induced production of activated p53 tumor suppressor protein. Biochem Pharmacol 2006;72:1714-1723 (Pubitemid 44765004)
9. Zhang J, Hsu JC, Kinseth MA, Bjeldanes LF, Firestine GL. Indole-3-carbinol induces a G1 cell cycle arrest and inhibits prostate-specific antigen production in human LNCaP prostate cancer cells. Cancer 2003;98:2511-2520 (Pubitemid 37466668)
10. Takada Y, Andreeff M, Aggarwal BB. Indole-3-carbinol suppresses NFκB and IκBα kinase activation, causing inhibition of expression of NFκB-regulated antiapoptotic and metastatic gene products and enhancement of apoptosis in myeloid and leukemia cells. Blood 2005;106:641-649
11. Wu H-T, Lin S-H, Chen YH. Inhibition of cell proliferation and in vitro markers of angiogenesis by indole-3-carbinol, a maker indole metabolite present in cruciferous vegetables. J Agric Food Chem 2005;53:5164-5169
12. Aggarwal BB, Ichikawa H. Molecular targets and anticancer potential of indole-3-carbinol and its derivatives. Cell Cycle 2005;4:1201-1215
13. Sarkar FH, Rahman W, Li Y. Bax translocation to mitochondria is an important event in inducing apoptosis cell death by indole-3-carbinol (I3C) treatment of breast cancer cells. J Nutr 2003;133:2434-9S, Review.
14. Kirsh VA, Peters U, Mayne ST, et al. Prospective study of fruit and vegetable intake and risk of prostate cancer. J Natl Cancer Inst 2007;99:1200-1209 (Pubitemid 47233070)
15. Higdon JV, Delage B, Williams DE, Dashwood RH. Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis. Pharmacol Res 2007;55:224-236
16. Kong D, Banerjee S, Huang W, et al. Mammalian target of rapamycin repression by 3,3′-diindolylmethane inhibits invasion and angiogenesis in platelet-derived growth factor-D-overexpressing PC-3 cells. Cancer Res 2008;68:1927-1934
17. NTR tumor suppressor protein. Cancer Res 2004;64:6207-6213
18. NTR-dependent decreased survival of prostate tumor cells. Cancer Res 2007;67:3254-3262
19. Khwaja F, Tabassum A, Allen J, et al. The p75 (NTR) tumor suppressor induces cell cycle arrest facilitating caspase mediated apoptosis in prostate tumor cells. Biochem Biophys Res Commun 2006;341:1184-1192
20. NTR in prostate cancer cells. Cancer Res 2007;67:11402-11410
21. Sporn MB, Suh N. Chemoprevention: an essential approach to controlling cancer. Nat Rev Cancer 2002;2:537-543
22. Gupta S. Prostate cancer chemoprevention: current status and future prospects. Toxicol Appl Pharmacol 2007;224:369-376
23. Fleshner N, Zlotta AR. Prostate cancer prevention. Cancer 2007;110:1889-189943.
24. Fleshner N, Bagnell PS, Klotz L, Venketeswaran V. Dietary fat and prostate cancer. J Urol 2004;171:S19-24.
25. Kirsh VA, Peters U, Mayne ST, et al. Prospective study of fruit and vegetable intake and risk of prostate cancer. J Natl Cancer Inst 2007;99:1200-1209 (Pubitemid 47233070)
26. Higdon JV, Delage B, Williams DE, Dashwood RH. Cruciferous vegetables and human cancer risk: epidemiological evidence and mechanistic basis. Pharmacol Res 2007;55:224-236
27. Anderton MJ, Manson MM, Williams ML, Mager DE. Physiological modeling of formulated and crystalline 3,3′-diindolylmethane pharmacokinetics following oral administration in mice. Drug Metab Dispos 2004;32:632-638
28. Bhuiyan MMR, Li Y, Banerjee S, et al. Down-regulation of androgen receptor by 3,3′-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells. Cancer Res 2006;66:10064-10072
29. NTR is a tumor suppressor in human prostate cancer. Anticancer Res 2001;21:3749-3755
30. NTR suppresses growth and nerve growth factor-mediated metastasis of human prostate cancer cells. Int J Cancer 2002;98:1-7.
31. NTR lipoplex. Anticancer Res 2004;24:2997-3003.
32. NTR loss of the expression in human prostate tumor cells. Mol Carcinog 2001;31:46-55.
33. NTR dependent apoptosis via the p38 MAPK pathway in prostate cancer cells. Mol Cancer Ther 2008;7:3539-3545
34. Garikapaty VP, Ashok BT, Tadi K, Mittelman A, Tiwari RK. Synthetic dimer of indole-3-carbinol: Second generation diet derived ant-cancer agent in hormone sensitive prostate cancer. Prostate 2006;66:453-462
35. Nachshon-Kedmi M, Yannai S, Haj A, Fares FA. Indole-3-carbinol and 3,3′diindolylmethane induce apoptosis in human prostate cancer cells. Food Chem Toxicol 2003;41:745-752
36. Kong D, Li Y, Wang Z, Banerjee S, Sarkar FH. Inhibition of angiogenesis and invasion by 3,3′-diindolylmethane is mediated by the nuclear factor-κB downstream target genes MMP-9 and uPA that regulate bioavailability of vascular endothelial growth factor in prostate cancer. Cancer Res 2007;67:3310-3319
37. NTR metastasis suppressor inhibits urokinase plasminogen activator, matrix metalloproteinase-2 and matrix metalloproteinase-9 in PC-3 prostate cancer cells. Clin Exp Metastasis 2006;23:107-116
38. Abdelrahim M, Newman K, Vanderlagg K, Samudio I, Safe S. 3,3′-diindolylmethane (DIM) and its derivatives induce apoptosis in pancreatic cancer cells through endoplasmic reticulum stress-dependent upregulation of DR5. Carcinogenesis 2006;27:717-728
39. Xue L, Firestone GL, Bjeldanes LF. DIM stimulates IFNγ gene expression in human breast cancer cells via the specific activation of JNK and p38 pathways. Oncogene 2005;24:2343-2353
40. Zarubin T, Han J. Activation and signaling of the p38 MAP kinase pathway. Cell Res 2005;15:11-18
41. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995;270:1326-1331
42. NTR mediates a bifurcated signal transduction cascade through the NFκB and JNK pathways to inhibit cell survival. Exp Cell Res 2005;304:69-80.